Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state.
Nat Med. 2020 Dec;26(12):1865-1877. doi: 10.1038/s41591-020-1073-3. Epub 2020 Oct 19.
Nat Med. 2020.
PMID: 33077955